{"pmid":32234457,"title":"COVID-19 in children: More than meets the eye.","text":["COVID-19 in children: More than meets the eye.","Travel Med Infect Dis","Hagmann, Stefan H F","32234457"],"journal":"Travel Med Infect Dis","authors":["Hagmann, Stefan H F"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32234457","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.tmaid.2020.101649","keywords":["COVID-19","Children","Morbidity","SARS-CoV-2"],"source":"PubMed","topics":["Epidemic Forecasting"],"weight":1,"_version_":1662996001700446208,"score":7.6048946,"similar":[{"pmid":32232980,"title":"COVID-19 epidemic: disease characteristics in children.","text":["COVID-19 epidemic: disease characteristics in children.","In mid-December 2019, a disease caused by infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which began in Wuhan, China, has spread throughout the country and many countries around the world. The number of children with coronavirus disease-2019 (COVID-19) has also increased significantly. Although information regarding the epidemiology of COVID-19 in children has accumulated, relevant comprehensive reports are lacking. The present article reviews the epidemiological characteristics of COVID-19 in children. This article is protected by copyright. All rights reserved.","J Med Virol","Jiatong, She","Lanqin, Liu","Wenjun, Liu","32232980"],"abstract":["In mid-December 2019, a disease caused by infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which began in Wuhan, China, has spread throughout the country and many countries around the world. The number of children with coronavirus disease-2019 (COVID-19) has also increased significantly. Although information regarding the epidemiology of COVID-19 in children has accumulated, relevant comprehensive reports are lacking. The present article reviews the epidemiological characteristics of COVID-19 in children. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Jiatong, She","Lanqin, Liu","Wenjun, Liu"],"date":"2020-04-02T11:00:00Z","year":2020,"_id":"32232980","week":"202014|Mar 30 - Apr 05","doi":"10.1002/jmv.25807","keywords":["COVID-19","Children","Epidemiological characteristics","SARS-CoV-2"],"source":"PubMed","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Transmission"],"weight":1,"_version_":1662899337651290112,"score":56.82395},{"pmid":32222992,"title":"Detectable SARS-CoV-2 Viral RNA in Feces of Three Children during Recovery Period of COVID-19 Pneumonia.","text":["Detectable SARS-CoV-2 Viral RNA in Feces of Three Children during Recovery Period of COVID-19 Pneumonia.","Coronavirus Disease 2019 (COVID-19) is a newly emerging infectious disease caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). After its first occurrence in Wuhan of China from December 2019, COVID-19 rapidly spread around the world. According to the World Health Organization (WHO) statement on March 13, 2020, there had been over 132,500 confirmed cases globally. Nevertheless, the case reports of children are rare, which result in the lack of evidence for preventing and controlling of children's infection. Here, we report 3 cases of SARS-CoV-2 infected children diagnosed from February 3 to February 17, 2020 in Tianjin, China. All of these three cases experienced mild illness and recovered soon after treatment, with the nucleic acid of throat swab turning negative within 14, 11, 7 days after diagnosis respectively. However, after been discharged, all the three cases were tested SARS-CoV-2 positive in the stool samples within 10 days, in spite of their remained negative nucleic acid in throat swab specimens. Therefore, it is necessary to be aware of the possibility of fecal-oral transmission of SARS-CoV-2 infection, especially for children cases. This article is protected by copyright. All rights reserved.","J Med Virol","Zhang, Tongqiang","Cui, Xiaojian","Zhao, Xue","Wang, Jinhu","Zheng, Jiafeng","Zheng, Guifen","Guo, Wei","Cai, Chunquan","He, Sijia","Xu, Yongsheng","32222992"],"abstract":["Coronavirus Disease 2019 (COVID-19) is a newly emerging infectious disease caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). After its first occurrence in Wuhan of China from December 2019, COVID-19 rapidly spread around the world. According to the World Health Organization (WHO) statement on March 13, 2020, there had been over 132,500 confirmed cases globally. Nevertheless, the case reports of children are rare, which result in the lack of evidence for preventing and controlling of children's infection. Here, we report 3 cases of SARS-CoV-2 infected children diagnosed from February 3 to February 17, 2020 in Tianjin, China. All of these three cases experienced mild illness and recovered soon after treatment, with the nucleic acid of throat swab turning negative within 14, 11, 7 days after diagnosis respectively. However, after been discharged, all the three cases were tested SARS-CoV-2 positive in the stool samples within 10 days, in spite of their remained negative nucleic acid in throat swab specimens. Therefore, it is necessary to be aware of the possibility of fecal-oral transmission of SARS-CoV-2 infection, especially for children cases. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Zhang, Tongqiang","Cui, Xiaojian","Zhao, Xue","Wang, Jinhu","Zheng, Jiafeng","Zheng, Guifen","Guo, Wei","Cai, Chunquan","He, Sijia","Xu, Yongsheng"],"date":"2020-03-31T11:00:00Z","year":2020,"_id":"32222992","week":"202014|Mar 30 - Apr 05","doi":"10.1002/jmv.25795","keywords":["COVID-19","Children","Clinical characteristics","SARS-CoV-2"],"source":"PubMed","locations":["Pneumonia","Wuhan","Feces","China","Tianjin"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1662715354764279809,"score":52.10794},{"pmid":32191173,"title":"Serial Interval of COVID-19 among Publicly Reported Confirmed Cases.","text":["Serial Interval of COVID-19 among Publicly Reported Confirmed Cases.","We estimate the distribution of serial intervals for 468 confirmed cases of 2019 novel coronavirus disease reported in China as of February 8, 2020. The mean interval was 3.96 days (95% CI 3.53-4.39 days), SD 4.75 days (95% CI 4.46-5.07 days); 12.6% of case reports indicated presymptomatic transmission.","Emerg Infect Dis","Du, Zhanwei","Xu, Xiaoke","Wu, Ye","Wang, Lin","Cowling, Benjamin J","Meyers, Lauren Ancel","32191173"],"abstract":["We estimate the distribution of serial intervals for 468 confirmed cases of 2019 novel coronavirus disease reported in China as of February 8, 2020. The mean interval was 3.96 days (95% CI 3.53-4.39 days), SD 4.75 days (95% CI 4.46-5.07 days); 12.6% of case reports indicated presymptomatic transmission."],"journal":"Emerg Infect Dis","authors":["Du, Zhanwei","Xu, Xiaoke","Wu, Ye","Wang, Lin","Cowling, Benjamin J","Meyers, Lauren Ancel"],"date":"2020-03-20T11:00:00Z","year":2020,"_id":"32191173","week":"202012|Mar 16 - Mar 22","doi":"10.3201/eid2606.200357","keywords":["2019 novel coronavirus disease","COVID-19","China","SARS-CoV-2","Wuhan","coronavirus","epidemiology","respiratory infections","serial interval","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Epidemic Forecasting","Transmission"],"weight":1,"_version_":1662334543462400000,"score":50.5198},{"pmid":32244365,"title":"A Systematic Review of COVID-19 Epidemiology Based on Current Evidence.","text":["A Systematic Review of COVID-19 Epidemiology Based on Current Evidence.","As the novel coronavirus (SARS-CoV-2) continues to spread rapidly across the globe, we aimed to identify and summarize the existing evidence on epidemiological characteristics of SARS-CoV-2 and the effectiveness of control measures to inform policymakers and leaders in formulating management guidelines, and to provide directions for future research. We conducted a systematic review of the published literature and preprints on the coronavirus disease (COVID-19) outbreak following predefined eligibility criteria. Of 317 research articles generated from our initial search on PubMed and preprint archives on 21 February 2020, 41 met our inclusion criteria and were included in the review. Current evidence suggests that it takes about 3-7 days for the epidemic to double in size. Of 21 estimates for the basic reproduction number ranging from 1.9 to 6.5, 13 were between 2.0 and 3.0. The incubation period was estimated to be 4-6 days, whereas the serial interval was estimated to be 4-8 days. Though the true case fatality risk is yet unknown, current model-based estimates ranged from 0.3% to 1.4% for outside China. There is an urgent need for rigorous research focusing on the mitigation efforts to minimize the impact on society.","J Clin Med","Park, Minah","Cook, Alex R","Lim, Jue Tao","Sun, Yinxiaohe","Dickens, Borame L","32244365"],"abstract":["As the novel coronavirus (SARS-CoV-2) continues to spread rapidly across the globe, we aimed to identify and summarize the existing evidence on epidemiological characteristics of SARS-CoV-2 and the effectiveness of control measures to inform policymakers and leaders in formulating management guidelines, and to provide directions for future research. We conducted a systematic review of the published literature and preprints on the coronavirus disease (COVID-19) outbreak following predefined eligibility criteria. Of 317 research articles generated from our initial search on PubMed and preprint archives on 21 February 2020, 41 met our inclusion criteria and were included in the review. Current evidence suggests that it takes about 3-7 days for the epidemic to double in size. Of 21 estimates for the basic reproduction number ranging from 1.9 to 6.5, 13 were between 2.0 and 3.0. The incubation period was estimated to be 4-6 days, whereas the serial interval was estimated to be 4-8 days. Though the true case fatality risk is yet unknown, current model-based estimates ranged from 0.3% to 1.4% for outside China. There is an urgent need for rigorous research focusing on the mitigation efforts to minimize the impact on society."],"journal":"J Clin Med","authors":["Park, Minah","Cook, Alex R","Lim, Jue Tao","Sun, Yinxiaohe","Dickens, Borame L"],"date":"2020-04-05T11:00:00Z","year":2020,"_id":"32244365","week":"202014|Mar 30 - Apr 05","doi":"10.3390/jcm9040967","keywords":["COVID-19","SARS-CoV-2","basic reproduction number","epidemiology","incubation period","serial interval","severity"],"source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Transmission","Epidemic Forecasting","Prevention"],"weight":1,"_version_":1663169699618226176,"score":50.5198},{"pmid":32168463,"title":"Case-Fatality Risk Estimates for COVID-19 Calculated by Using a Lag Time for Fatality.","text":["Case-Fatality Risk Estimates for COVID-19 Calculated by Using a Lag Time for Fatality.","We estimated the case-fatality risk for 2019 novel coronavirus disease cases in China (3.5%); China, excluding Hubei Province (0.8%); 82 countries, territories, and areas (4.2%); and on a cruise ship (0.6%). Lower estimates might be closest to the true value, but a broad range of 0.25%-3.0% probably should be considered.","Emerg Infect Dis","Wilson, Nick","Kvalsvig, Amanda","Barnard, Lucy Telfar","Baker, Michael G","32168463"],"abstract":["We estimated the case-fatality risk for 2019 novel coronavirus disease cases in China (3.5%); China, excluding Hubei Province (0.8%); 82 countries, territories, and areas (4.2%); and on a cruise ship (0.6%). Lower estimates might be closest to the true value, but a broad range of 0.25%-3.0% probably should be considered."],"journal":"Emerg Infect Dis","authors":["Wilson, Nick","Kvalsvig, Amanda","Barnard, Lucy Telfar","Baker, Michael G"],"date":"2020-03-14T11:00:00Z","year":2020,"_id":"32168463","week":"202011|Mar 09 - Mar 15","doi":"10.3201/eid2606.200320","keywords":["2019 novel coronavirus disease","COVID-19","SARS-CoV-2","case-fatality risk","coronaviruses","pandemic","respiratory diseases","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"source":"PubMed","locations":["Hubei","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Epidemic Forecasting"],"weight":1,"_version_":1662334543713009664,"score":50.476376}]}